IRIS
BUONOMO, ANTONIO RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.971
EU - Europa 1.222
AS - Asia 1.178
SA - Sud America 49
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.911
SG - Singapore 655
IT - Italia 512
HK - Hong Kong 264
CN - Cina 203
NL - Olanda 189
DE - Germania 159
RU - Federazione Russa 112
FI - Finlandia 72
IE - Irlanda 66
CA - Canada 53
BR - Brasile 43
CI - Costa d'Avorio 34
GB - Regno Unito 29
CH - Svizzera 21
IN - India 20
AT - Austria 18
FR - Francia 17
VN - Vietnam 9
EG - Egitto 7
LT - Lituania 6
BE - Belgio 5
MX - Messico 5
BD - Bangladesh 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
ID - Indonesia 3
PK - Pakistan 3
SE - Svezia 3
TH - Thailandia 3
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
IR - Iran 2
KE - Kenya 2
MK - Macedonia 2
PH - Filippine 2
PL - Polonia 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
OM - Oman 1
SI - Slovenia 1
TR - Turchia 1
Totale 4.466
Salva come PNG Salva come JPEG
Città #
Singapore 373
Chandler 294
Hong Kong 264
Ashburn 194
Santa Clara 191
Amsterdam 169
Naples 138
Millbury 81
Des Moines 61
Napoli 61
Nanjing 53
Boston 47
Ottawa 45
Princeton 45
Boardman 43
Lawrence 35
Beijing 34
Seattle 33
Krefeld 32
Rome 28
Wilmington 23
Helsinki 22
Basel 17
Shenyang 16
Washington 16
Nanchang 15
Los Angeles 13
Hebei 11
Jiaxing 11
Milan 11
Nuremberg 11
Frankfurt am Main 10
Caserta 8
Falkenstein 8
Boise 7
Düsseldorf 7
Indiana 7
Marseille 7
Dublin 6
Kronberg 6
Lappeenranta 6
Pomigliano D'arco 6
Pune 6
Redwood City 6
The Dalles 6
Tianjin 6
Afragola 5
Changsha 5
Guangzhou 5
London 5
Munich 5
Vienna 5
Bologna 4
Brussels 4
Cercola 4
Council Bluffs 4
Dallas 4
Dong Ket 4
Norwalk 4
Pozzuoli 4
Qualiano 4
Rochdale 4
Toronto 4
Brasília 3
Brescia 3
Cairo 3
Caivano 3
Catania 3
Chicago 3
Dung 3
Hanover 3
Jinan 3
Montalbano Jonico 3
Ravenna 3
Roncoferraro 3
Shenzhen 3
Vilnius 3
Zhengzhou 3
Baku 2
Bern 2
Caravaggio 2
Castellammare Di Stabia 2
Castellammare di Stabia 2
Dearborn 2
Espoo 2
Fairfield 2
Formia 2
Fremont 2
Gualtieri 2
Guarulhos 2
Houston 2
Hyderabad 2
Manassas 2
Mexico City 2
Moscow 2
Naaldwijk 2
Olomouc 2
Paris 2
Phoenix 2
Prato 2
Totale 2.652
Salva come PNG Salva come JPEG
Nome #
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 139
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 76
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 73
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 67
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 63
Human Platelet Antigen Genotypes As Predictors of Liver Cirrhosis In Patients With Hcv Chronic Infection 62
Asunaprevir for hepatitis C: A safety evaluation 61
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 61
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 59
Discontinued drugs in 2012 - 2013: Hepatitis C virus infection 59
Does compulsory vaccination limit personal freedom? Ethical issues 59
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 57
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 55
ABT-450: A novel protease inhibitor for the treatment of hepatitis C virus infection 51
Central venous catheter related bloodstream infections in adult patients on home parenteral nutrition: Prevalence, predictive factors, therapeutic outcome 51
The serum-ascites vitamin D gradient (SADG): A novel index in spontaneous bacterial peritonitis 51
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 50
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 50
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 50
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 49
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A 49
Exposure to Varicella Zoster Virus is higher in children with autism spectrum disorder than in healthy controls. Results from a case-control study. 49
Beclabuvir for the treatment of hepatitis C 49
Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study 49
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 49
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy 49
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 48
Current evidence on the management of hepatitis B in pregnancy 48
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 47
Studio sulla conoscenza dell’antibioticoterapia tra i medici di un ospedale universitario di terzo livello 47
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 47
Human platelet antigen 3 genotype predicts platelet count in patients with HCV infection 46
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 45
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak 45
Fecal microbiota transplantation for Clostridium difficile infection: Back to the future 44
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 44
Direct acting antiviral agents and hepatocellular carcinoma development: Don't take it for granted 43
Efficacy of the "first wave" Direct Acting antivirals against HCV infection: results from the Italian LINA (Liver Network Activity) cohort 43
A standardized polyphenol mixture extracted from poplar-type propolis for remission of symptoms of uncomplicated upper respiratory tract infection (URTI): A monocentric, randomized, double-blind, placebo-controlled clinical trial 43
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 43
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 42
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 41
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 41
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 40
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 40
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 40
Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma 40
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 39
Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world? 39
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens 39
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 39
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 38
Diabetes and COVID-19: The potential role of mTOR 38
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 38
Infections worsen prognosis of patients with cirrhosis irrespective of the liver disease stage 38
Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience 38
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? 38
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 37
The therapeutic potential of new investigational hepatitis C virus translation inhibitors 37
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 37
Epilobium angustifolium L. extract with high content in oenothein B on benign prostatic hyperplasia: A monocentric, randomized, double-blind, placebo-controlled clinical trial 36
Ledipasvir : a novel synthetic antiviral for the treatment of HCV infection. 36
Efficacy and safety of a fixed dose combination tablet of asunaprevir + beclabuvir + daclatasvir for the treatment of Hepatitis C 36
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 35
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 35
Trends in Caesarean Section Rate According to Robson Group Classification among Pregnant Women with SARS-CoV-2 Infection: A Single-Center Large Cohort Study in Italy 34
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 34
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 33
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 33
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications 33
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 32
Prevalence of herpes simplex virus 1 and 2 antibodies in patients with autism spectrum disorders. 32
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus 32
Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. 32
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 32
Unsolved issues in the treatment of spontaneous peritonitis in patients with cirrhosis: Nosocomial versus community-acquired infections and the role of fungi 32
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 32
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series 31
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 31
Prevalence and titre of antibodies to cytomegalovirus and epstein-barr virus in patients with autism spectrum disorder. 31
Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection 31
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 30
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 30
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection 30
Prevalence of Pneumocystis jirovecii Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study) 30
Severe Vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC 30
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection 29
Efficacy and Safety of Sofosbuvir in Treatment of Chronic Hepatitis C: The Dawn of the a New Era. 29
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 28
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 27
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient. 27
SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience 27
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 26
Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience 26
In vivo antiviral activity of telbivudine against HIV-1: a case report. 26
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection. 26
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 25
Influence of ITPase activity on decreases of hemoglobin during treatment with Interferon-free DAA-based and ribavirin in HCV-related cirrhosis 25
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 24
Investigational direct-acting antivirals in hepatitis C treatment: the latest drugs in clinical development 24
Totale 4.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.305
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 0 0 0 0 2 11 35 17
2020/2021139 23 3 7 5 10 19 8 4 18 19 11 12
2021/2022479 2 4 0 4 3 21 3 19 64 44 116 199
2022/2023985 85 60 23 50 99 107 26 181 124 178 37 15
2023/2024807 26 112 131 68 66 119 8 70 18 12 91 86
2024/20251.682 139 159 16 78 105 257 419 258 251 0 0 0
Totale 4.702